<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04260165</url>
  </required_header>
  <id_info>
    <org_study_id>HUS/3487/2019</org_study_id>
    <nct_id>NCT04260165</nct_id>
  </id_info>
  <brief_title>Proximal Row Carpectomy vs Four-corner Fusion for Osteoarthritis of the Wrist</brief_title>
  <acronym>PROOF</acronym>
  <official_title>A Double-blinded Randomized Controlled Multicenter Trial Comparing Proximal ROw carpectOmy and Four-corner Fusion (PROOF) for Osteoarthritis of the Wrist</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Töölö Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jyväskylä Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kymenlaakso Central Hospital Kotka Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Töölö Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study purpose is to compare the outcome after proximal row carpectomy (PRC) vs four-corner
      fusion (FCA) for SLAC/SNAC II-III type osteoarthritis (OA) in a double-blinded randomized
      controlled study setting.

      Patients with radiologically and clinically confirmed OA are randomized (1:1 computer
      generated sequence with random block size) to two parallel groups and will undergo either PRC
      or FCA. The study will be patient and assessor blinded.

      Baseline data is collected preoperatively and is followed by a follow-up visits at 2 and 6
      weeks, 3, 6, 12 months, and 5, 10 years after the intervention. Unveiling of the allocation
      is at 12 months post-intervention.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2034</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient-Rated Wrist Evaluation</measure>
    <time_frame>12 months</time_frame>
    <description>The PRWE comprises 15 questions to measure wrist pain and disability in daily activities. In PRWE patients rate wrist pain and disability from 0 to 10 and it consists two subscales: Pain and Function (0=best possible outcome, 10=worst possible outcome)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quick-Disabilities of the Arm, Shoulder and Hand</measure>
    <time_frame>12 months</time_frame>
    <description>The QuickDASH is self-reported questionnaire and shortened version of DASH outcome measure to measure physical function and symptoms in people with any or multiple musculoskeletal disorders of the upper limb in 11 dimensions in 1-5 scale (1=best possible outcome, 5=worst possible outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain (Visual Analogue Scale)</measure>
    <time_frame>12 months</time_frame>
    <description>The VAS is derived by health care professional question of pain in scale 0 to 10 (0=no pain, 10=worst possible pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global improvement</measure>
    <time_frame>12 months</time_frame>
    <description>Global rating to treatment effect will be evaluated by question: &quot;How would you rate the function of your hand compared to the situation before the treatment?&quot;. The options are in 5-step Likert scale from (-2) Much worse to (+2) Much better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength</measure>
    <time_frame>12 months</time_frame>
    <description>Grip strength is measured with a dynamometer in kg as the mean of three measurements. It will be numbered in kg and percentage of the unaffected side</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wrist range of motion (ROM)</measure>
    <time_frame>12 months</time_frame>
    <description>Wrist ROM is measured on both wrists with a handheld goniometer in degrees.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>12 months</time_frame>
    <description>Incidence of complications (i.e. non-union, fracture, reoperation, infection, hematoma, iatrogenic tendon/nerve/arterial injury, complex regional pain syndrome) is recorded and compared between study groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-rated Quality of Life (EQ-5D)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>12 months</time_frame>
    <description>Quality-adjusted life years/months measured as a change in EQ-5D</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Wrist Osteoarthritis</condition>
  <condition>Scapholunate Advanced Collapse</condition>
  <arm_group>
    <arm_group_label>Proximal Row Carpectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Four-corner fusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Proximal Row Carpectomy</intervention_name>
    <description>Excision of the proximal carpal row - the scaphoid, lunate and triquetrum</description>
    <arm_group_label>Proximal Row Carpectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Four-corner fusion</intervention_name>
    <description>Scaphoid excision and four-corner fusion with cannulated headless compression screws/dorsal plate</description>
    <arm_group_label>Four-corner fusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  SLAC/SNAC II-III

          -  Age 18 - 75

          -  Symptom duration &gt; 3 months

          -  American Society of Anaesthesiologists physical status (ASA) I-II

        Exclusion Criteria:

          -  Patient eligible for SL reconstruction or scaphoid

          -  Ulnocarpal/pancarpal arthritis

          -  Lunate fossa, proximal lunate arthrosis or both

          -  Age &lt;18 or &gt;75 years

          -  Rheumatoid arthritis

          -  Heavy smoking (&gt; 20 cigarettes per day)

          -  Condition or medication affecting bony healing (eg diabetes mellitus with poor
             glycemic control, malnutrition, use of per oral corticosteroids)

          -  Alcohol or drug abuse

          -  Neurological condition affecting upper limb function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Samuli Aspinen, MD, PhD</last_name>
    <phone>+358406360546</phone>
    <email>samuli.aspinen@hus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jorma Ryhänen, adj. prof.</last_name>
    <email>jorma.ryhanen@hus.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Töölö Hospital (Helsinki University Hospital)</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Samuli Aspinen, M.D., Ph.D.</last_name>
      <phone>+358406360546</phone>
      <email>samuli.aspinen@hus.fi</email>
    </contact>
    <contact_backup>
      <last_name>Jorma Ryhänen, adj. prof</last_name>
      <email>jorma.ryhanen@hus.fi</email>
    </contact_backup>
    <investigator>
      <last_name>Eero Waris, adj. prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susanna Stjernberg-Salmela, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mikko Alanen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Hospital of Central Finland</name>
      <address>
        <city>Jyväskylä</city>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Teemu Karjalainen, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kymenlaakso Central Hospital</name>
      <address>
        <city>Kotka</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <contact>
      <last_name>Hanna-Stiina Taskinen, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 5, 2020</study_first_submitted>
  <study_first_submitted_qc>February 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2020</study_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Töölö Hospital</investigator_affiliation>
    <investigator_full_name>Samuli Aspinen</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Wrist Osteoarthritis</keyword>
  <keyword>Scapholunate Advanced Collapse</keyword>
  <keyword>Scaphoid Non-union Advanced Collapse</keyword>
  <keyword>Wrist arthrodesis</keyword>
  <keyword>Proximal Row Carpectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

